FKFrederic Khiami

Frederic Khiami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Frederic Khiami has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Return to Sport and Return to Self-Reported Preinjury Level After Surgical Repair of Acute Achilles Tendon Rupture: A 2-Year Prospective Cohort Analysis

    by Maxime Guerot, Frederic Khiami, Eugénie Valentin, Olivier Grimaud, Mohamad K. Moussa, Antoine Gerometta, Alain Meyer, Nicolas Lefèvre, Alexandre Hardy

    Background: Achilles tendon ruptures are among the most common sports injuries. The literature reports highly variable “return to sport” (RTS) rates depending on the study, as the definition of return to play is not consistent. Our purpose was to assess RTS and self-reported relative performance level after surgical management of acute Achilles tendon ruptures. Method: In this retrospective analysis of a prospective cohort, the RTS rate and the return to self-reported preinjury level (RTPIL) in patients treated surgically for acute Achilles tendon rupture between November 2020 and September 2023 with at least 2 years of follow-up were reported. The primary outcomes were the RTS and RTPIL rates at last follow-up. Secondary outcomes were Patient-Reported Outcome Measures (PROMS): Achilles Tendon Total Rupture Score (ATRS), Ankle Ligament Reconstruction–Return to Sport after Injury (ALR-RSI), Foot and Ankle Ability Measure (FAAM), Tegner Activity Scale (TAS) and the University of California and Los Angeles (UCLA) activity level rating scale. Data was collected preoperatively; at three, six, twelve, and twenty-four months postoperatively; and then every two months thereafter. Kaplan–Meier analysis was performed to measure time to RTS and RTPIL. Results: In the final analysis, 65 patients were included for analysis of RTS and RTPIL, and 69 for the PROMS. In total, 81.7% (58) were male, and the mean age was 40.6 years (SD 12.5). The RTS rate was 76.9%, and the RTPIL rate was 44.6%. The mean delay to RTS was 11.6 months (SD 7.6). The median time to RTS was approximately 14 months (95% CI, 10.0–18.0). The RTPIL rate continued to increase between the first and second years after surgery. At the last follow-up, the median ATRS was 89 with an interquartile range (IQR) of [77.0–95.0], ALR-RSI was 80 [62.5–95.0], FAAM activity was 91.7 [85.7–97.6], FAAM sport was 85.9 [68.8–96.9], TAS was 7 [5–7], and UCLA was 10 [9–10]. Median follow-up was 24.8 months. Conclusions: In conclusion, self-reporting of RTS and RTPIL yields low rates, and caution should be used in overly optimistic preoperative counselling. Level of evidence: IV.

  • Open Access

    Return to Sports and Activities after Arthroscopic Treatments for Rotator Cuff Lesions in Young Patients Less Than 45-Years-Old: A Systematic Review

    by Mohamad K. Moussa, Elena Lang, Antoine Gerometta, Karam Karam, Mickael Chelli, Olivier Grimaud, Nicolas Lefèvre, Ryan Bou Raad, Yoann Bohu, Frédéric Khiami, et al.

    Background: To evaluate the outcomes of arthroscopic treatment of rotator cuff tear (RCT) in individuals under 45 years, focusing on their ability to return to sports (RTS) and work, along with different patient-reported outcomes (PROMs). Methods: Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, this systematic review encompassed articles that studied the outcomes of arthroscopic treatment of RCT in the young population (those under 45 years old). The literature search was conducted in PubMed/Medline and EMBASE until 21 May 2024. The primary outcome was the RTS, with secondary outcomes including the return to work and various PROMs. These PROMs included the American Shoulder and Elbow Surgeons (ASES) score and 10 other PROMs. Results: Out of 6267 articles, 15 met the inclusion criteria, involving 659 patients, predominantly male athletes with a weighted mean age of 28.3 years. The RCT etiology (14 studies) was primarily traumatic (72.3%), followed by chronic microtrauma in overhead athletes (16.8%) and non-traumatic (10.9%). The RTS rate (12 studies) varied between 47% and 100%, with a cumulative rate of 75.2%. The cumulative rate of return to the same or higher RTS level (11 studies) was 56.1%. Excluding non-athletes and patients treated with debridement, the RTS rates increased to 79.8% (143/179) overall, with a 61% (108/177) rate of returning to the same or higher level. The return to work (3 studies) was successful in 90.6% of cases. Postoperative ASES scores (5 studies) improved markedly to a weighted post-operative mean of 75.6, with similar positive trends across other PROMs. Conclusions: Young adults undergoing arthroscopic RCT repair typically experience a 75% RTS rate at any level, and 56.1% RTS at the same level. Excluding non-athletes and debridement patients, RTS rates rise to 79.8% (143/179), with 61% (108/177) achieving the same or higher level. Level of evidence: IV, systematic review including case series.


  • Open Access

    Dynamic intermittent compression cryotherapy with intravenous nefopam results in faster pain recovery than static compression cryotherapy with oral nefopam: post‐anterior cruciate ligament reconstruction

    by Mohamad K. Moussa, Nicolas Lefevre, Eugenie Valentin, Alain Meyer, Olivier Grimaud, Yoan Bohu, Antoinne Gerometta, Frederic Khiami, Alexandre Hardy

    Purpose: To evaluate the effectiveness of dynamic intermittent compression cryotherapy (DICC) (CryoNov®) with an intravenous nefopam‐based pain management protocol (DCIVNPP) in reducing post‐operative pain following anterior cruciate ligament reconstruction (ACLR) compared to static compression cryotherapy (SCC) (Igloo®) and oral Nefopam.Methods: This was a retrospective analysis of prospectively collected data including 676 patients who underwent primary ACLR in 2022. Patients were either in the DCIVNPP group or in the SCC (control group), and were matched for age, sex, and Lysholm and Tegner scores (338 per arm). The primary outcome was pain on the visual analogue scale (VAS), analyzed in relation to the minimal clinically important difference (MCID) and the Patient Acceptable Symptom State (PASS) thresholds for VAS. The secondary outcome was side effects.Results: Postoperative pain in the DCIVNPP group was less severe on the VAS than in the control group (p < 0.05). The maximum difference in the VAS between groups was 0.57, which is less than the MCID threshold for VAS. The DCIVNPP group crossed the PASS threshold for VAS on Day 3, sooner than the control group. The side effect profiles were similar in both groups except for higher rates of dizziness and malaise in the DCIVNPP group, and higher rates of abdominal pain in the control group. Most of the side effects decreased over time in both groups, with no significant side effects after Day 3.Conclusion: DCIVNPP effectively allows for faster pain recovery than in the control group. The difference in side effects between the protocols may be due to mode of administration of nefopam.Level of evidence: III.